CerS2 ko in vivo reduces pro-inflammatory ceramides and improves doxorubicin mediated cardiotoxicity
25 August 2023 (07:30 - 18:30)
Organised by: 
About the speaker
University hospital Jena, Jena (Germany)
6 More presentations in this session
Doctor I. Cheang (Nanjing, CN)
Prognostic value of 6-minute walking test for early prediction of doxorubicin induced cardiotoxicity
Mrs G. Muckiene (Kaunas, LT)
Doctor G. Oristrell Santamaria (Barcelona, ES)
Associate Professor K. Urbanek (Naples, IT)
Access the full session
The Event
ESC Congress 2023
25 August - 28 August 2023
You may be interested in
Congress Session
Congress Session
